MaSS - Maastricht Sarcopenia Study (MaSS)

January 18, 2016 updated by: Maastricht University Medical Center

Cross-sectional Study on the Identification and Characterization of Community-dwelling Older People With Sarcopenia

The objective of this cross-sectional study is to obtain insight in the characteristics (nutritional status and level of physical activity) of sarcopenic compared to non-sarcopenic community-dwelling older people. There is one measurement moment and measurements will take place at the participant's home.

Study Overview

Status

Completed

Conditions

Detailed Description

  • Characterization of sarcopenic older people (demographics, nutritional status, level of physical activity)
  • Prevalence rates of sarcopenia in community-dwelling older people in the Netherlands
  • Insight in differences and/or overlap between sarcopenia versus frailty
  • Insight in the impact of sarcopenia on economic outcomes

Study Type

Observational

Enrollment (Actual)

247

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Netherlands
      • Maastricht, Netherlands
        • Maastricht University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 99 years (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Community-dwelling older people

Description

Inclusion Criteria:

  • ≥ 65 years old
  • Have given informed consent
  • Understand Dutch language
  • Able to perform a walk test

Exclusion Criteria:

  • Older people living in a nursing home
  • Older people with active rheumatoid arthritis, post stroke status with evident lingering symptoms (paralysis, loss of motor functions), diseases of the nervous system like Parkinson and MS, active angina pectoris, dementia
  • Older people in a wheelchair, with ICD or pacemaker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Sarcopenic vs. non-sarcopenic
Participants are classified as sarcopenic/non-sarcopenic according to the criteria of the European Working Group of Sarcopenia in Older People (EWGSOP).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mean difference in nutritional status and level of physical activity of sarcopenic participants vs. non-sarcopenic participants, as a measure of a Food Frequency Questionnaire and Mini-Nutritional Assessment Tool and Minnesota questionnaire
Time Frame: 1 home visit
1 home visit

Secondary Outcome Measures

Outcome Measure
Time Frame
Prevalence of sarcopenia in community-dwelling older people
Time Frame: 1 home visit
1 home visit
Number of sarcopenic participants with frailty as a measure of the FRAIL scale and Fried criteria
Time Frame: 1 home visit
1 home visit
Health care costs by sarcopenic vs. non-sarcopenic participants, measured by health care use
Time Frame: 1 home visit
1 home visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Maastricht University Medical Center

Collaborators

Nutricia Research Fundation

Investigators

  • Study Director: J.M.G.A. Schols, Prof. Dr., Maastricht University
  • Principal Investigator: R.J.G. Halfens, PhD, Maastricht University
  • Principal Investigator: J.M.M. Meijers, PhD, Maastricht University
  • Principal Investigator: D.M. Mijnarends, MSc, Maastricht University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (Actual)

March 1, 2014

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

March 12, 2013

First Submitted That Met QC Criteria

March 26, 2013

First Posted (Estimate)

March 29, 2013

Study Record Updates

Last Update Posted (Estimate)

January 20, 2016

Last Update Submitted That Met QC Criteria

January 18, 2016

Last Verified

April 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • METC 13-3-006

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe